{
  "id": 20546323,
  "title": "Lotte Biologics Completes Songdo Plant 1, Accelerates Global CDMO Market Expansion",
  "url": "https://urgent.news/2026/11/18/lotte-biologics-completes-songdo-plant-1-accelerates-global-cdmo",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-18T04:54:51.000Z",
  "source": {
    "name": "Korea IT Times",
    "slug": "korea-it-times",
    "url": "https://www.koreaittimes.com/news/articleView.html?idxno=159298"
  },
  "original_language": "en",
  "account": null,
  "summary": "Lotte Biologics has successfully completed the construction of its first biopharmaceutical manufacturing facility, Plant 1, at its Songdo Bio Campus in Incheon, marking a significant step in its expansion into the global contract development and manufacturing organization (CDMO) market. The opening ceremony, held on November 18, was attended by high-profile guests including Lotte Group Chairman Shin Dong-bin, Co-CEOs James Park and Shin Yoo-yeol, government officials, and industry representatives. The facility's completion not only establishes a robust domestic manufacturing base for Lotte Group's biotechnology business but also aligns with the company's strategic vision to become a long-term manufacturing partner offering quality, advanced technology, and reliability to global customers. Early contract wins, including a major agreement with a global pharmaceutical company and a 10-year deal with Alvotech, have bolstered Lotte Biologics' initial production outlook by securing manufacturing contracts before the plant's official opening.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}